MedTrace Logo

Efficacy of the Apollo System for Children With ADHD

NCT05308706 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-04-20

No results posted yet for this study

Summary

To determine the extent to which the Apollo System is effective in reducing symptomatology associated with ADHD.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Interventions

DEVICE

8 weeks of home based use.

Use of the devices for an 8 week study period. Devices are preset to follow a scheduled activation pattern during the day.

Sponsors & Collaborators

Principal Investigators

  • Matthew B Pontifex, PhD. · Michigan State University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-18
Primary Completion
2027-08-15
Completion
2027-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05308706 on ClinicalTrials.gov